Biotech news
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016
Africa
The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”. 29 April 2016
Americas
A group of biotechnology industry associations has stepped into the Ariosa v Sequenom dispute, which may be reviewed by the US Supreme Court. 25 April 2016
Biotech
New industry body the British Biosimilars Association has officially launched in the UK. 19 April 2016
Americas
Regeneron Pharmaceuticals has agreed a licensing deal that it says will enable it to advance CRISPR/Cas gene-editing technology. 14 April 2016
Asia
The Indian government has invited public comments on draft regulatory guidelines for biosimilars, while patent law in this area has still to take shape. Sameer Sah, Nisha Austine and Jahnvi Shah of Khaitan & Co report. 14 April 2016
Pharma
Law firm Dentons has hired Campbell Forsyth as a partner in the firm’s intellectual property practice in London. 14 April 2016
Americas
Biotechnology company MorphoSys has sued both Janssen Biotech and Genmab in a patent infringement lawsuit centring on a drug used to treat myeloma, a form of cancer. 12 April 2016
Africa
The US has been ranked as the country that contributes most to global biopharmaceutical innovation through the use of its policies. 11 April 2016